The domestic Methaxatin industry has a high degree of concentration and good prospects for future industry development.

Methaxatin is also known as PQQ, pyrroloquinoline quinone, and its chemical name is 4,5-dihydro-4,5-dioxo-1hydro-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylic Acid, also known as Methaxatin, has a molecular formula of C14H6N2O8. It is a reddish-brown water-soluble ortho-quinone compound that is easily decomposed by light and is thermally stable. It is a coenzyme that participates in the redox reaction of dehydrogenase in organisms and participates in electron transfer in the respiratory chain. It has functions such as promoting body growth, protecting liver damage, promoting nerve growth factor synthesis, regulating the body’s free radical levels, and improving cell tolerance to toxicity and extreme conditions. It is mainly used in the food industry as a food additive.

From the perspective of the industry structure, due to the small market capacity of Methaxatin and the existence of technical barriers and customer resource barriers in the industry, at this stage, there are only a small number of Methaxatin production companies in China. Representative companies include Zhucheng Haotian Pharmaceutical Co., Ltd. and Shandong Jincheng Pharmaceutical Group Co., Ltd., Fuzhou Kangtai Biotechnology Co., Ltd., Anhui Xinximeng Biotechnology Co., Ltd., Shandong Tianming Pharmaceutical Group Co., Ltd., etc.

According to the released “2023-2028 China Methaxatin Industry Market In-depth Research and Development Prospects Forecast Report“, in 2022, Zhucheng City Haotian Pharmaceutical Co., Ltd., Shandong Jincheng Pharmaceutical Group Co., Ltd., Fuzhou Kangtai Biotechnology Co., Ltd., Anhui Xinximeng Biotechnology Co., Ltd., and Shandong Tianming Pharmaceutical Group Co., Ltd. have a combined Methaxatin production share of more than 80%.

In terms of domestic market demand, Methaxatin was approved as a new food ingredient in the National Health Commission’s Announcement No. 1 of 2022 in March 2022, and its use in other fields has not yet been approved. Therefore, Methaxatin applications are concentrated in the food and feed fields. . The high concentration of Methaxatin downstream application fields is not conducive to reducing market risks, increasing the operating income of Methaxatin production companies and expanding the market demand for Methaxatin.

Methaxatin can support the growth and development of mitochondria, stimulate the rapid growth of human cells, and has good antioxidant properties, which can help remove free radicals and reduce cell damage. Therefore, it has many benefits in brain health, cardiovascular health, metabolic health, etc. It has powerful effects, and the human body cannot synthesize Methaxatin by itself, so it needs to be supplemented through dietary supplements and other forms. Analysts believe that in the future, as consumption upgrades and residents’ health awareness increases, more and more consumers will begin to pay attention to dietary supplements. , which will promote the growth of METHAXATIN application demand in the food industry.

Methaxatin, as a new type of vitamin-like substance, can promote body growth, improve poultry reproductive capacity, antioxidant, anti-stress ability and enhance immunity. Adding an appropriate amount of Methaxatin to feed can improve the quality of poultry to a certain extent. In addition, Methaxatin can also be used as an aquatic feed additive. As a major poultry and aquatic animal breeding country, my country has a large demand for feed products. As the breeding industry’s requirements for the quality and efficacy of feed products increase, and the price of Methaxatin products declines, the demand for Methaxatin in the high-end feed field is also expected to increase.